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A systematic review of the methods and drugs used for 
performing suprascapular nerve block injections for the non-
surgical management of chronic shoulder pain. 
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Abstract 
Suprascapular nerve block injections are growing in popularity as a treatment option 
for people with chronic shoulder pain. The optimal method of injection and aftercare is 
unknown. This review describes the current methods and drugs used for performing 
suprascapular nerve block injections in the non-surgical management of adults with chronic 
shoulder pain in order to inform future research in this area.  
Systematic searches of CINAHL, Medline (OVID), AMED, EMBASE databases and 
The Cochrane Library were undertaken from inception to June 2020. Data on the method and 
drugs used for injection and aftercare was extracted and summarised for areas of 
commonality and discrepancy.  
We included 53 studies in this review. In total 8 different injection methods were 
reported within the included studies. Indirect surface land-marked methods were the most 
common method reported in 21 studies. Direct surface land-marked methods were reported in 
12 studies. Ultrasound guided methods used alone, were reported in 16 studies. Both 
fluoroscopy and computer tomography methods used alone, were reported in 1 study each. 
Electromyography was used in combination with other injection methods in 9 studies. Wide 
variation in the composition of the injectate was observed between studies. Local anaesthetic 
was used within injectate preparations in all studies.  Local anaesthetic used alone was 
reported in 20 studies, combined with steroid in 29 studies and combined with various other 
components in 5 studies. Physiotherapy following injection was reported in 26 studies. 
Reported details of physiotherapy varied considerably.  
This review identified substantial variation in the methods and drugs used to perform 
suprascapular nerve block injection in clinical trials. Current literature is inadequate to 
define best practice in suprascapular nerve block injection. Consensus research defining 
best practice suprascapular nerve block injection is now needed in order to standardise the 
approach for a future multi-centre clinical trial to evaluate its effectiveness. 
Key words: Suprascapular nerve block, Shoulder pain. 
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1. Introduction 
Chronic shoulder pain is a major cause of disability.1 Its prevalence is between 2.4 -14%. 
Around 20% of those affected report shoulder pain at one year and 14% of people report 
shoulder pain at three years.2,3 Annually approximately 1.5 million GP consultations are related 
to shoulder pain in England alone with the total annual societal costs of shoulder pain in the 
United Kingdom (UK) estimated to be £100 million.4
Shoulder pain can arise from multiple structures, making a clinical diagnosis challenging.5 The 
best treatment for people with persistent shoulder pain is uncertain. Physiotherapy is often the 
first line treatment for shoulder pain. Local steroid injections can provide short term benefit for 
up to three months6 and are used for the management of shoulder pain within physiotherapy 
practice.7–10 At best local steroid injections have short term benefits.6 Repeat local steroid 
injections may have negative effects on tendon homeostasis, healing, and future treatment 
outcomes for some patients.11–14 Suprascapular nerve block injections may offer an effective 
alternative to local steroid injections for some patients and there is growing interest in their use 
including within physiotherapy practice.15,16
The suprascapular nerve is a mixed motor and sensory nerve that supplies approximately 70% 
of the sensory innervation to the shoulder complex.17,18  Injections aiming to block the 
suprascapular nerve are used in the management of a range of chronic shoulder conditions.15,19
The mechanisms contributing to the clinical effectiveness of SSNB injections are unclear.20
SSNB injections are recommended in the British Elbow and Shoulder Society (BESS) 
guidelines for the management of chronic subacromial shoulder pain21 and glenohumeral 
osteoarthritis.22
A 2018 survey of BESS medical consultant and registrar members found that around 40% of 
respondents would use SSNB injection in the management of patients with large and massive 
rotator cuff tears.16 A 2019 survey of UK physiotherapists who regularly treat patients with 
shoulder pain found that the most common shoulder condition that they would consider using 
SSNB injections for was rotator cuff tear arthropathy (glenohumeral joint osteoarthritis 
associated with cuff tears).15 Some authors suggest that people with large to massive rotator 
cuff tears may also have an element of suprascapular neuropathy that may be more responsive 
to a SSNB injection.23
There is limited research surrounding the effectiveness of SSNB injections in these patient 
groups and compared to local steroid injections.19,24 Multiple methods and drugs are used for 
SSNB injections.25 The optimum method and aftercare has not been defined. Defining best 
practice in SSNB injections, and the adjunct physiotherapy interventions used are first steps 
towards designing robust randomised controlled trials. The aim of this review was to identify 
the methods and drugs used for performing SSNB injections for people with chronic shoulder 




2.1 Search methods and strategy 
Electronic searches of CINAHL, Medline (OVID), AMED, EMBASE, and The Cochrane 
Library were conducted from inception to June 2020. The electronic search was supplemented 
by hand searching of reference lists of retrieved full text articles and citation searching. The 
search strategy and search terms were developed with the support of a medical librarian (SJ). 
Search strategies for all databases are available in appendix one. 
2.2 Study Selection
Screening for relevant articles by title and abstract was undertaken independently by the lead 
author (NS). Full text articles were then assessed for eligibility using the predefined inclusion 
and exclusion criteria (Box 1) by two researchers independently (NS, ZL). Where there were 
discrepancies in decisions made between the two reviewers, these articles were forwarded to a 
third reviewer (RK) who made a final decision. Full text articles that met the inclusion criteria 
were included in this review. 
2.3 Data extraction and synthesis 
Data on the SSNB injection method used, the components making up the injectate and 
whether physiotherapy was delivered following the injection was extracted into predefined 
data extraction tables. A narrative synthesis of the findings is presented. 
Results 
3.1 Study selection 
Our search returned 3552 results from which we removed 980 duplicates. We screened a total 
of 2572 records by title and abstract.  We retrieved and assessed 89 full text articles for 
eligibility of which 53 were included. Articles excluded were recorded at the different stages 
of the eligibility screening process and reported in a PRISMA (preferred reporting items for 
systemic reviews and meta-analysis) flow diagram (Fig. 1).  
3.2 Study characteristics 
We included 53 studies from 14 different countries in this review (Table 1). Of which 13 
studies came from Turkey,26–38 7 each from Australia20,23,39–43 and India,44–50 6 from the UK,51–
56 4 each from the USA57–60 and South Korea,61–64 2 each from Brazil,65,66 Canada,67,68
Egypt69,70 and Italy71,72 and 1 each from Columbia,73 Austria,74 Nepal75 and Thailand.76
We included 28 randomised controlled trials (RCTs),23,26,27,29–31,33,35,36,38,41–44,46,48–
52,55,57,61,67,68,70,72,76 21 observational studies,20,28,32,34,37,39,45,53,54,57,58,62–66,69,71,73–75 3 audits40,59,60
and 1 service evaluation.56 Participant numbers were generally small within the included RCTs 
ranging from 10 participants76 to 100 participants.47,49 Of the included observational studies 
again participant numbers were generally small ranging from 9 participants58  to 102 
participants.64 The largest number of SSNB injections reported within a single study was from 
5
a retrospective audit of patient records that included 1005 SSNB injections undertaken within 
a Community Rheumatology service in Australia.40
3.3 Population and shoulder conditions 
A wide range of shoulder disorders were included in this review. Of the 53 studies included, 
15 were undertaken with participants with a diagnosis of frozen shoulder,28,30,46–49,55,57,58,64,65,68–
70,75 10 with participants with post stroke shoulder pain,26,27,29,32,33,35,43,63,71,76 and 10 with  
participants with a range of different musculoskeletal shoulder disorders.37,41,42,44,56,60,62,66,67,74
6 studies were undertaken with participants with rotator cuff related shoulder pain, of which 2 
were with participants  with a diagnosis of impingement syndrome,31,36 and 1 each with 
participants with rotator cuff tears,23 rotator cuff disease,20 rotator cuff tendinitis and / or tears51
and rotator cuff tendinitis.72 4 studies were undertaken with participants who had either a 
musculoskeletal shoulder disorder or a neurological condition causing their shoulder 
pain.40,50,53,73 3 studies were undertaken with participants with non-specific shoulder pain, 
where no diagnosis was provided.38,45,61 1 study was undertaken in participants with 
rheumatoid arthritis,52 either rheumatoid arthritis and /or osteoarthritis,54 myofascial trigger 
point shoulder pain,59 motor neurone disease,39 and with participants who developed shoulder 
pain following mastectomy for breast cancer.34
3.4 Injection methods 
A variety of different surface land-marked and guided SSNB injection methods were reported 
within the included studies (Fig. 2).
Surface land-marked methods without any use of guidance were used in 32 studies. Of these 
the indirect surface land-marked approach was reported in 20 studies20,36,39–44,50,53–
55,57,65,68,69,72,74–76 and the direct suprascapular notch surface land-marked approach was 
reported in 10 studies.27,29,30,35,38,51,56,59–61 In 1 study the direct spinoglenoid notch method was 
used45 and in 1 study a combination of both the direct suprascapular notch and indirect method 
was used.52 Ultrasound guidance used alone was reported in 16 
studies.23,26,27,32,34,46,47,49,50,56,61,63,64,66,70,71  Fluoroscopy used alone and Computer topography 
(CT) used alone was each reported  in 1 study.62 41 The additional use of Electromyography 
(EMG) was reported in 9 studies,  of which 4 combined EMG with a surface-landmarked 
method,30,35,48,58 3 combined EMG with fluoroscopy28,33,67 and 2 combined EMG with 
ultrasound.37,73 From the studies included in our review the earliest injection method reported 
was the land-marked direct suprascapular notch method in 1986.60 The land-marked indirect 
method was first reported in 1994.53 The earliest guided SSNB injection methods reported were 
EMG guided in 1992,58 CT guided in 2004,41 ultrasound guided in 201061 and fluoroscopy 
guided in 2012.62 The most commonly reported injection method within the last decade was 
ultrasound guided SSNB injections in 16 studies (Fig. 3). 
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Of the 53 studies included in this review 6 studies compared different injection methods. 1 
study compared ultrasound guided injection with the land-marked indirect method. 50 2 studies 
compared ultrasound guided injection with the land-marked direct method. 56,61  2 studies 
compared EMG land-marked with the land-marked direct method 30,35 and 1 study compared 
CT guided injection to the land-marked indirect method. 41
3.5 Medication used 
In total 21 different combinations of medication were used within the injectates for SSNB 
injection for the studies included in this review with Bupivacaine combined with 
Methylprednisolone being the most common in 12 studies (Fig. 4). 
Local anaesthetic was used in all 53 studies. Local anaesthetics were used alone in 20
studies,27,29,58–60,62,63,67,68,70,74,76,30,33,37,38,46,49,54,57 used with steroid in 29 studies20,23,26,28,32,34–
36,39–45,47,48,50–53,55,56,64,66,69,71,73,75 and used with a combination of steroid and other injectate 
components such has saline,27,72 serum,32 adrenaline65 and dextrose61 in a further 5 studies. No 
study used steroid alone (Fig. 5). 
Bupivacaine was the most common local anaesthetic used at various concentrations and 
volumes in 30 studies.20,31,46,47,49–53,55,58,59,33,60,64–66,68–71,73,75,34,39–44 Of which 24 studies reported 
using 0.5% Bupivacaine20,31,46,49,51–53,55,64,65,68,69,33,70,71,73,75,34,39–44 and 6 studies reported using 
0.25% Bupivacaine.47,50,58–60,66 Bupivacaine was used at different volumes ranging from 10ml 
of 0.5% Bupivacaine,20,39–44,55,64,68,70,71 3ml of 0.25% Bupivacaine 66  to 1ml of 0.5% 
Bupivacaine.51
Lidocaine was the choice of local anaesthetic used in 16 
studies.26,27,61,63,67,72,75,76,28,30,32,38,45,48,56,57 Of which 10 studies reported using 1% 
Lidocaine,28,30,38,45,56,57,63,67,75,76 4 studies used 2% Lidocaine,26,27,61,72 and 2 studies used 10% 
Lidocaine.32,48 Lidocaine was used at various volumes ranging from 2ml of 10%,32 2ml of 2%61
and 2ml of 1%67 Lidocaine to 10ml of 1% Lidocaine.30,38,45,56,76 A combination of Lidocaine 
[5ml,1%] mixed with Bupivacaine [4ml,0.5%] was used in 1 study.75
Prilocaine was used in 5 studies.29,35–37,54 Of which, Prilocaine 2% was used in 3 studies29,36,37
and Prilocaine 1% used in 2 studies.35,54 The volume of Prilocaine ranged from 10ml of 2% 
Prilocaine29 to 4ml of 1% Prilocaine. 54
Ropivacaine was used in 2 studies.23,74 Of which, 1 study used 1ml of 1% Ropivacaine23 and 1 
study used 5ml of 0.5% Ropivacaine.74
Mepivacaine [2ml,1%] was used in 1 study.62
The lowest volume of local anaesthetic used was 1ml of 1% Ropivacaine combined with 1ml 
of Betamethasone delivered by ultrasound.23 The largest volume of local anaesthetic used was 
10ml of 0.5% Bupivacaine,20,39–44,55,64,68,70,71 10ml of 1% Lidocaine,30,38,45,56,76 10ml of 2% 
Lidocaine72 and 10ml of 2% Prilocaine29 by both land-marked and ultrasound guided 
techniques. The largest dosage of local anaesthetics reported was 400mg of  Lidocaine 
[4ml/10%] injected using EMG guidance,48 200mg of Lidocaine [2ml/10%] injected using 
ultrasound guidance32 and 200mg of Lidocaine  [10ml/2%] delivered land-marked.72 Conversely 
the smallest dosage of local anaesthetic used was 5mg of Bupivacaine [1ml/ 0.5%] injected using 
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the surface land-marked direct suprascapular notch method.51 The mean dosage of Bupivacaine 
used was 36.25mg for land-marked and 28.18mg for guided methods. The mean dosage of 
Lidocaine used was 107mg for land-marked  and 130mg for guided methods (Fig. 6). 
Methylprednisolone was the most common steroid used in combination with local anaesthetic 
in 16 studies.20,28,39–45,47,50,51,53,56,71,75 Of which, 40mg was used in 15 studies20,28,39–
45,47,50,51,56,71,75 and 80mg was used in 1 study.53 Triamcinolone was used in 7 
studies.26,34,36,48,55,64,66 Of which, 40mg was used in 4 studies26,36,48,66 and 20mg in 3 
studies.34,55,64 Betamethasone at a volume of 1ml was used in 4 studies.23,27,32,35 Dexamethasone 
was used in 2 studies.69,73 Of which 1 study reported using 1ml of Dexamethasone69 and the 
other study reported using 4mg of Dexamethasone.73 Prednisolone 40mg was used in 1 study.52
Only 1 study compared the effectiveness of SSNB injections given with or without steroid.66
3.6 Additional treatment following SSNB injections 
The use of physiotherapy as an adjunct intervention following SSNB injection  was reported 
in 26 studies (Table 2).23,26–28,31–34,36,43,44,46,48,49,55–58,63,64,68–70,72,75,76 Most physiotherapy 
interventions included some aspect of shoulder exercises, either physiotherapy led or in the 
form of home exercises with written and verbal advice after SSNB injection. The specific 
details of the reported physiotherapy intervention and exercises varied considerably between 
studies. No study evaluated if physiotherapy maximised any potential benefit or improved 
long term outcomes in participants after SSNB injection.   
4.0 Discussion 
The aim of this systematic review was to identify the methods and drugs used for performing 
SSNB injections in the management of chronic shoulder pain and what adjunct physiotherapy 
interventions are used following injection. We have not included studies of modulation 
techniques targeting the suprascapular nerve. This is an important piece of work but is beyond 
the scope of this review which we have done to inform future research on injections used for 
SSNBs. Similarly, we are not seeking to draw any conclusions here on the clinical effectiveness 
of SSNBs. A systematic review is needed but is, again, a separate piece of work. 
In our systematic review we found that a variety of injection methods and medications can be 
used for SSNB injections. The direct surface land-marked method first described by Wertheim 
and Rovenstine (1941)77 was reported in 12  studies in our review. This direct approach aims 
to deliver the injectate directly into the suprascapular notch where the suprascapular nerve 
enters the scapular. The direct approach is reported to pose a greater risk of pneumothorax, 
nerve damage and veno-puncture, due to potential needle tip injury to the suprascapular nerve, 
suprascapular blood vessels and the apex of the lung if the needle tip penetrates too deeply 
through the suprascapular notch, compared to the indirect approach.40
Dangoisse et al (1994)53 demonstrated that it was not essential to use the direct suprascapular 
notch approach for SSNB injection. An indirect approach where a deposit of 5-10 ml of 
injectate delivered deep into the supraspinatus fossa, away from the suprascapular notch, was 
sufficient to fill the supraspinatus fossa and bathe the suprascapular nerve, thereby reducing 
the risks associated with the direct approach.53 The indirect approach was a common method, 
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reported in 20 studies in our review. The indirect approach appears to be a safe and well 
tolerated method of SSNB injection. A retrospective case audit of over 1005 SSNB injections, 
administered utilising the indirect approach, revealed no serious complications with this 
method.40
In total 16 studies utilised ultrasound guidance for SSNB injections in our review. Ultrasound 
guided approaches were  the most common method for SSNB injection within our review for 
studies  published within the last decade, presumably due to technological advances, training 
opportunities and equipment availability. The earliest study in our review using ultrasound 
guidance for SSNB injection was in 2010.61 Ultrasound guidance removes the radiation risks 
associated with other guided approaches such has fluoroscopy and CT guided injections which 
appear to have become less common over time. Although the use of ultrasound guidance may 
be needed for accurate needle placement for denervation procedures at the suprascapular nerve 
at present there is insufficient evidence regarding the efficacy of ultrasound guided SSNB 
injections compared to surface land-marked SSNB injection approaches.24
Some authors suggest that using guided nerve block methods facilitates the use of lower drug 
dosages to achieve effective blockade, however  this was not always consistent with the trends 
and patterns of practice reported within studies in our review. In fact, the largest dosage of 
local anaesthetic used was 400mg of Lidocaine [4ml/10%] delivered utilising EMG48 and the 
smallest dosage of local anaesthetic used was 5mg of Bupivacaine [1ml/ 0.5%] injected using 
the surface land-marked direct suprascapular notch method.51
Within the 53 studies in this review 21 different variations of drugs were used for SSNB 
injections, with further variation in the volumes and concentrations of drugs. Local anaesthetic 
was used alone in 20 studies, combined with steroid in 29 studies and combined with various 
other components in 5 studies. Robust evidence supporting the addition of corticosteroid to 
local anaesthetic in the hope it prolongs the duration of nerve blockade or the effectiveness of 
nerve block injection is lacking.78 Only 1 small study undertaken with 34 stroke patients 
compared the effectiveness of SSNB injection with and without the addition of steroid.66
Although a trend in favour of the addition of steroid was seen no statistical differences were 
observed in pain scores post injection compared to placebo injection and SSNB given with 
local anaesthetic alone.   At present it remains unclear if the addition of corticosteroid to local 
anaesthetic for SSNB injection improves outcomes.  
This review indicates that injection method, choice of drug, drug dosage, volume and 
concentration, used for SSNB injection may be based upon clinician preference rather than 
evidence based. Although physiotherapy interventions were commonly employed following 
SSNB injection, in 26 of the studies included in this review, there was wide variation in the 
interventions and methods of delivery. Many of the studies included in our review had 
heterogenous cohorts of patients with mixed shoulder conditions. Although patients with large 
to massive rotator cuff tears and patients with rotator cuff arthropathy appear to be common 
patients groups selected to receive SSNB injection in clinical practice in the UK15,16
interestingly our review found no clinical trials specifically focusing on these patient groups to 
support this trend.  
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5.0 Conclusion  
This review identified substantial variation in the methods and drugs used to perform SSNB 
injection in clinical trials. Standardisation of the delivery method and drug used for SSNB 
injection is required in order to evaluate its effectiveness in a multi-centre clinical trial. The 
current literature is inadequate to define best practice in SSNB injection for 
standardisation in a future clinical trial. Consensus research on defining best practice in 
SSNB injection is therefore now needed. This will ensure delivery of the intervention is 
standardised, can be delivered consistently across different trial sites, and is reproducible in 
clinical practice. 
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